maintain News newsbot.ch

Wirtschaft »

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

2019-09-27 14:20:09


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-06-10 12:40:00


Wirtschaft »

Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases

2019-06-02 12:20:56


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-04-03 15:40:15


Wirtschaft »

European Commission approves Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

2019-03-08 10:20:06


Wirtschaft »

Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash

2019-03-07 19:20:03


Wirtschaft »

Roche und Spark Therapeutics schliessen verbindliche Übernahmevereinbarung

2019-02-25 19:20:33


Wirtschaft »

Roche enters into definitive merger agreement to acquire Spark Therapeutics

2019-02-25 09:20:18


Wirtschaft »

CHMP recommends EU approval of Roche’s Tecentriq in combination with Avastin and chemotherapy as an initial treatment for lung cancer

2019-02-01 16:40:01


Wirtschaft »

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) - other company programmes in AD continue

2019-01-30 06:40:12


Wirtschaft »

FDA approves Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer

2018-12-07 06:40:32


Wirtschaft »

New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia

2018-12-04 07:20:00


Inland »

A commitment to maintain and deepen our relations with Jordan (en)

2018-05-13 23:52:03


Inland »

A commitment to maintain and expand our relations with Jordan (en)

2018-05-13 18:52:11



Suchresultate als RSS-Feed